Lower functioning predicts identification of psychosis risk screening status in help-seeking adolescents

Early Intervention in Psychiatry

Volumn 9, Issue 5, 2015, Pages 363-369

  Granö, Niklas ^a   Kallionpää, Santeri ^a   Karjalainen, Marjaana ^a   Edlund, Virve ^a   Saari, Erkki ^a   Itkonen, Arja ^a   Anto, Jukka ^a   Roine, Mikko ^a  

^a JORVI HOSPITAL   (Finland)

Author keywords

Adolescents; Functioning ability; Psychosis risk screening status

Indexed keywords

ADOLESCENT; ADOLESCENT BEHAVIOR; AGE; ALCOHOL CONSUMPTION; ANXIETY; ARTICLE; BECK ANXIETY INVENTORY; BECK DEPRESSION INVENTORY; BECK HOPELESSNESS SCALE; DEPRESSION; FEMALE; FINLAND; FUNCTIONAL STATUS; GLOBAL ASSESSMENT OF FUNCTIONING; HELP SEEKING BEHAVIOR; HOPELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RISK FACTOR; SEX DIFFERENCE; COMPLICATION; EARLY DIAGNOSIS; PATIENT ATTITUDE; PREDICTIVE VALUE; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOTIC DISORDERS; STATISTICAL MODEL;

ADOLESCENT; ADOLESCENT BEHAVIOR; ANXIETY; DEPRESSION; EARLY DIAGNOSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUALITY OF LIFE; RISK FACTORS;

EID: 84940889405     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/eip.12118     Document Type: Article

References (60)

1. Kao Y-C, Liu Y-P, Lu C-W. Beck hopelessness scale: exploring its dimensionality in patients with schizophrenia. Psychiatr Q 2011; 83: 241-255.
2. Häfner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Könnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases - a controlled study of schizophrenia, depression and healthy controls. Schizophr Res 2005; 77: 11-24.
3. Narvaez JM, Twamley EW, McKibbin CL, Heaton RK, Patterson TL. Subjective and objective quality of life in schizophrenia. Schizophr Res 2008; 98: 201-208.
4. Green MF, Kern RS, Braff DL, Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the 'right stuff'? Schizophr Bull 2000; 26: 119-136.
5. Achim AM, Maziade M, Raymond E, David O, Chantal M, Marc-Andre R. How prevalent are anxiety disorders in schizophrenia? A meta-analysis and critical review on a significant association. Schizophr Bull 2011; 37: 811-821.
6. Norman RM, Malla AK, Corteze L, Diaz F. Aspects of dysphoria and symptoms of schizophrenia. Psychol Med 1998; 28: 1433-1441.
7. Ballon JS, Kaur T, Marks II, Cadenhead KS. Social functioning in young people at risk for schizophrenia. Psychiatr Res 2007; 151: 29-35.
8. Cornblatt BA, Auther AM, Niendam T etal. Preliminary findings for two new measures of social and role functioning in the prodromal phase of schizophrenia. Schizophr Bull 2007; 33: 688-702.
9. Addington J, Penn D, Woods SW, Addington D, Perkins DO. Social functioning in individuals at clinical high risk for psychosis. Schizophr Res 2008; 99: 119-124.
10. Cannon TD, Cadenhead K, Cornblatt B etal. Prediction of psychosis in youth at high clinical risk. Arch Gen Psychiatry 2008; 65: 28-37.
11. Svirskis T, Korkeila J, Heinimaa M etal. Quality of life and functioning ability in subjects vulnerable to psychosis. Compr Psychiatry 2007; 48: 155-160.
12. Bechdolf A, Pukrop R, Köhn D etal. Subjective quality of life in persons at high risk for a first episode psychosis: a comparison with first episode schizophrenia patients and healthy controls. Schizophr Res 2005; 79: 137-143.
13. Miller TJ, McGlashan TH, Rosen JL etal. Prodromal assessment with structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity interrater reliability, and training to reliability. Schizophr Bull 2003; 29: 703-715.
14. Svirskis T, Korkeila J, Heinimaa M etal. Axis-I disorders and vulnerability to psychosis. Schizophr Res 2005; 75: 439-446.
15. Yung AR, Phillips LJ, Yuen HP, McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res 2004; 67: 131-142.
16. Korkeila JA, Svirskis T, Heinimaa M. Substance abuse and related diagnoses in early psychosis. Compr Psychiatry 2005; 46: 447-452.
17. Häfner H, Löffer W, Maurer K, Hambrecht M, an der Heiden W. Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia. Acta Psychiatr Scand 1999; 100: 105-118.
18. Rietdijk J, Hogerzeil SJ, van Hemert AM, Cuijpers P, Linszen DH, van der Gaag M. Pathways to psychosis: help seeking behaviour in the prodromal phase. Schizophr Res 2011; 132: 213-219.
19. Yun DY, Hwang SS-H, Kim Y, Lee YH, Kim YS, Jung HY. Impairments in executive functions in patients with remitted and non remitted schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1148-1154.
20. Marshall C, Addington J, Epstein I, Liu L, Deighton S, Zipursky RB. Treating young Individuals at clinical high risk for psychosis. Early Interv Psychiatry 2012 6: 60-68.
21. Addington J, Epstein I, Liu L, French P, Boydell KM, Zipursky RB. A randomized controlled trial of cognitive behavioral therapy for individuals at clinical high risk of psychosis. Schizophr Res 2011; 125: 54-61.
22. Granö N, Karjalainen M, Anto J, Itkonen A, Edlund V, Roine M. Intervention to improve level of overall functioning and mental condition of adolescents at high risk of developing first-episode psychosis in Finland. Early Interv Psychiatry 2009; 3: 94-98.
23. Ziermans TB, Schothorst PF, Sprong M, van Engeland H. Transition and remission in adolescents at ultra-high risk for psychosis. Schizophr Res 2011; 126: 58-64.
24. Welsh P, Tiffin PA. The 'At-Risk Mental State' for psychosis in adolescents: clinical presentation, transition and remission. Child Psychiatry Hum Dev 2013. doi: 10.1007/s10578-013-0380-z.
25. Granö N, Karjalainen M, Edlund V etal. Health-related quality of life among adolescents: a comparison between subjects at risk for psychosis and other help seekers. Early Interv Psychiatry 2013 Jan 24. doi: 10.1111/eip.12033. [Epub ahead of print].
26. Granö N, Karjalainen M, Edlund V etal. Depression symptoms in help-seeking adolescents: a comparison between adolescents at-risk for psychosis and other help-seekers. J Ment Health 2013; 22: 317-324.
27. Granö N, Karjalainen M, Edlund V etal. Adolescents at risk for psychosis have higher level of hopelessness than adolescents not at risk of psychosis. Nord J Psychiatry 2013; 67: 258-264.
28. Granö N, Karjalainen M, Edlund V etal. Anxiety symptoms in adolescents at risk for psychosis: a comparison among help seekers. Child Adolesc Ment Health 2012 Dec 6. doi: 10.1111/camh.12012.
29. Granö N, Karjalainen M, Suominen K, Roine M. Poor functioning ability is associated with high risk of developing psychosis in adolescents. Nord J Psychiatry 2011; 65: 16-21.
30. Heinimaa M, Salokangas RK, Ristkari M etal. PROD-screen, a screen for prodromal symptoms of psychosis. Int J Methods Psychiatr Res 2003; 12: 92-104.
31. McGlashan T. Structured interview for prodromal symptoms. SIPS, Manual, New Haven, CT: Yale School of Medicine, 1998.
32. Häfner H, Riecher-Rössler A, Färkenheuer B, Maurer K, Meissner S, Löffler W. Interview for the retrospective assessment of the onset of schizophrenia (IRAOS). Translator G. Patton. Manual. Mannhein. Central Institute of Mental Health, 1992.
33. Gross G, Huber G, Klosterkötter J, Linz M. Bonner Scala fûr die Beurteilung von Basissymptomen (BSABS). Berlin: Springer, 1987.
34. Miller TJ, McGlashan TH, Rosen JL etal. Prospective diagnosis of the initial prodrome for schizophrenia based on the structural interview for prodromal symptoms: preliminary evidence of interrater reliability and predictive validity. Am J Psychiatry 2002; 59: 921-928.
35. Miller TJ, Zipursky RB, Perkins D etal. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the 'prodromal' sample. Schizophr Res 2003; 61: 19-30.
36. Lemos S, Vallina O, Fernandez P etal. Predictive validity of the scale of prodromal symptoms (SOPS). Actas Esp Psiquiatr 2006; 34: 216-223.
37. Steer RA, Beck AT. Dimensions of the Beck depression inventory-II in clinically depressed outpatients. J Clin Psychol 1999; 55: 117-128.
38. Beck AT, Steer RA, Brown GK. Manual for Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation, 1996.
39. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association, 1994.
40. Beck AT, Steer RA, Brown GK. BDI-II -Käsikirja. Helsinki: Psykologien kustannus OY, 2005.
41. Beck AT, Steer RA. Manual for Beck Anxiety Inventory. San Antonio, TX: Psychological Corporation, 1990.
42. Beck AT, Weissman A, Lester D, Trexler L. The measurement of pessimism: the hopelessness scale. J Consult Clin Psychol 1974; 42: 861-865.
43. Apajasalo M, Sintonen H, Holmberg C etal. Quality of life in early adolescence: a sixteen dimensional health related measure (16D). Qual Life Res 1996; 5: 205-211.
44. Sintonen H. The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001; 33: 328-336.
45. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption - II. Addiction 1993; 88: 791-804.
46. Hall R. Global assessment of functioning: a modified scale. Psychosomatics 1995; 36: 267-275.
47. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, Revised. Washington, DC: American Psychiatric Association, 1987.
48. Söderberg P, Tungström S, Armelius BÅ. Reliability of global assessment of functioning ratings made by clinical psychiatric staff. Psychiatr Serv 2005; 56: 434-438.
49. Phillips LJ, Francey SM, Edwards J, McMurray N. Stress and psychosis: towards the development of new models of investigation. Clin Psychol Rev 2007; 27: 307-317.
50. Zubin J, Spring G. Vulnerability - a new view of schizophrenia. J Abnorm Psychol 1977; 82: 103-126.
51. Liu SK, Hsieh MH, Huang TJ etal. Patterns and clinical correlates of neuropsychologic deficits in patients with schizophrenia. J Formos Med Assoc 2006; 105: 978-991.
52. Pukrop R, Ruhrman S, Schultze-Lutter F, Bechdolf A, Brockhaus-Dumke A, Klosterkötter J. Neurocognitive indicators for a conversion to psychosis: comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis. Schizophr Res 2007; 92: 116-125.
53. Yung AR, Nelson B, Stanford C etal. Validation of 'prodromal' criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up. Schizophr Res 2008; 105: 10-17.
54. Ruhrmann S, Schulze-Lutter F, Salokangas RK etal. Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 2010; 67: 241-251.
55. Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research. Schizophr Bull 2006; 32: 166-178.
56. Skeate A, Patterson P, Birchwood M. Transition to psychosis in a high-risk sample: the experience of ED: IT, Birmingham, UK. Schizophr Res 2004;70: 44.
57. Klosterkötter J, Hellmich M, Steinmeyer EM, Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 2001; 58: 158-164.
58. Salokangas RK, Heinimaa M, Svirskis T etal. Patient vulnerable to psychosis (in Finnish). Helsinki: The Social Insurance Institution, Finland, Studies in Social Security and Health 2007; 91: 62.
59. Schultze-Lutter F, Schimmelmann BG, Ruhrmann S. The near Babylonian speech confusion in early detection of psychosis. Schizophr Bull 2011; 37: 653-655.
60. Schimmelmann BG, Schultze-Lutter F. Early detection and intervention of psychosis in children and adolescents: urgent need for studies. Eur Child Adolesc Psychiatry 2012; 21: 239-241.